Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Vala Capital Partners
Better Ventures EIS
28th Mar 2023
Fidelity China Special Situations Plc
If you like China, why invest via FCSS?
23rd Mar 2023
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
72: What happened at Silicon Valley Bank and its effect on UK venture capital | Brian Moretta of Hardman & Co
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
R.E.A. Holdings
Agriculture
All Change From 2019
By
Yingheng Chen
13 Jun 2017
ValiRx
Life Sciences
Initiation: Developing novel cancer therapies
By
Dr Dorothea Hill
31 May 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Morses Club Plc
Financials
Opportunities abound
By
Mark Thomas
25 May 2017
Alliance Pharma Plc
Life Sciences
A transformational year driving growth
By
Dr Martin Hall
25 May 2017
Avacta Group plc
Life Sciences
Affimers 2 – Antibodies 0
By
Dr Martin Hall
24 May 2017
Chamberlin Plc
Industrial
On-track; Turbo-charging into a new growth phase
By
Paul Singer
23 May 2017
Burford Capital
Financials
Bond issue judged a great success
By
Dr Brian Moretta
19 May 2017
Titon Holdings
Building & Construction
60 percent ABV
By
Tony Williams
12 May 2017
Collagen Solutions Plc
Life Sciences
Trading update indicates earnings above forecasts
By
Dr Martin Hall
11 May 2017
Avacta Group plc
Life Sciences
De-risking of the partnership with Moderna
By
Dr Martin Hall
08 May 2017
Avacta Group plc
Life Sciences
Bringing forward the Affimer technology
By
Dr Martin Hall
05 May 2017
Prev
1
...
62
63
64
65
66
67
Next
